Welcome to KPI reports!
More details about the company.
Related Companies in Industry: medical instruments & supplies,NOTE: we may not be tracking all of them!
Tip: How to understand business better? Become a Business Analyst.
Ticker | Entry | 2023 | 2022 |
---|---|---|---|
ISRG | revenue from contract with customer::contract assets | 20.20M | 45.00M |
ISRG | revenue from contract with customer::deferred revenue | 491.70M | 438.30M |
Ticker | Entry | 2023 | 2022 |
---|---|---|---|
ISRG | revenue from contract with customer::contract assets | 4.11% | 10.27% |
ISRG | revenue from contract with customer::deferred revenue | 100.00% | 100.00% |
Ticker | Entry | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
ISRG | revenue recognized | 0.38B | 0.35B | 0.28B | 0.0 |
ISRG | operating lease, lease income, statement of income or comprehensive income [extensible enumeration]::operating lease revenue | 0.38B | 0.28B | 0.18B | 0.11B |
ISRG | remaining performance obligations::transaction price allocated to remaining performance obligations | 0.0 | 0.0 | 0.00B | 0.00B |
ISRG | revenue, remaining performance obligation, expected timing of satisfaction, start date [axis]: 2023-01-01::transaction price allocated to remaining performance obligations | 1.86B | 1.86B | 0.0 | 0.0 |
ISRG | sales-type lease, lease income, statement of income or comprehensive income [extensible enumeration]::sales-type lease revenue | 0.16B | 0.22B | 0.15B | 0.08B |
ISRG | variable lease revenue, usage-based arrangements::operating lease revenue | 0.13B | 0.08B | 0.03B | 0.0 |
Ticker | Entry | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|---|
ISRG | instruments and accessories::total revenue | 4.28B | 3.52B | 3.10B | 2.46B | 2.41B | 1.96B | 1.64B | 1.40B |
ISRG | ous | instruments and accessories::total revenue | 1.22B | 1.01B | 0.88B | 0.67B | 0.62B | 0.48B | 0.37B | 0.32B |
ISRG | ous | services::total revenue | 0.40B | 0.34B | 0.31B | 0.24B | 0.22B | 0.18B | 0.15B | 0.13B |
ISRG | ous | systems::total revenue | 0.81B | 0.71B | 0.67B | 0.48B | 0.52B | 0.43B | 0.32B | 0.30B |
ISRG | ous::total revenue | 2.44B | 2.06B | 1.86B | 1.40B | 1.35B | 1.09B | 0.85B | 0.75B |
ISRG | product::total revenue | 0.0 | 5.20B | 4.79B | 3.63B | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | services::total revenue | 1.17B | 1.02B | 0.92B | 0.72B | 0.72B | 0.64B | 0.57B | 0.51B |
ISRG | systems::total revenue | 1.68B | 1.68B | 1.69B | 1.18B | 1.35B | 1.13B | 0.93B | 0.80B |
ISRG | total::revenue | 7.12B | 6.22B | 5.71B | 4.36B | 4.48B | 3.72B | 3.14B | 2.71B |
ISRG | u.s. | instruments and accessories::total revenue | 3.06B | 2.51B | 2.23B | 1.78B | 1.79B | 1.49B | 1.26B | 1.08B |
ISRG | u.s. | services::total revenue | 0.76B | 0.68B | 0.60B | 0.48B | 0.51B | 0.46B | 0.42B | 0.38B |
ISRG | u.s. | systems::total revenue | 0.86B | 0.97B | 1.02B | 0.69B | 0.83B | 0.69B | 0.60B | 0.50B |
ISRG | u.s.::total revenue | 4.69B | 4.16B | 3.85B | 2.96B | 3.13B | 2.63B | 2.29B | 1.96B |
Ticker | Entry | 2022 | 2021 |
---|---|---|---|
ISRG | revenue recognized | 20.43% | 18.87% |
ISRG | operating lease, lease income, statement of income or comprehensive income [extensible enumeration]::operating lease revenue | 20.24% | 14.89% |
ISRG | remaining performance obligations::transaction price allocated to remaining performance obligations | 0.0 | 0.0 |
ISRG | revenue, remaining performance obligation, expected timing of satisfaction, start date [axis]: 2023-01-01::transaction price allocated to remaining performance obligations | 100.00% | 100.00% |
ISRG | sales-type lease, lease income, statement of income or comprehensive income [extensible enumeration]::sales-type lease revenue | 8.41% | 11.84% |
ISRG | variable lease revenue, usage-based arrangements::operating lease revenue | 7.15% | 4.20% |
Ticker | Entry | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|---|
ISRG | instruments and accessories::total revenue | 60.02% | 56.52% | 54.29% | 56.33% | 53.77% | 52.68% | 52.13% | 51.54% |
ISRG | ous | instruments and accessories::total revenue | 17.07% | 16.23% | 15.32% | 15.37% | 13.78% | 12.78% | 11.89% | 11.75% |
ISRG | ous | services::total revenue | 5.68% | 5.46% | 5.48% | 5.53% | 4.82% | 4.81% | 4.90% | 4.91% |
ISRG | ous | systems::total revenue | 11.43% | 11.48% | 11.70% | 11.08% | 11.50% | 11.65% | 10.32% | 11.01% |
ISRG | ous::total revenue | 34.18% | 33.17% | 32.50% | 32.01% | 30.12% | 29.27% | 27.15% | 27.71% |
ISRG | product::total revenue | 0.0 | 83.54% | 83.94% | 83.38% | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | services::total revenue | 16.38% | 16.46% | 16.04% | 16.59% | 16.17% | 17.05% | 18.23% | 18.84% |
ISRG | systems::total revenue | 23.57% | 27.00% | 29.65% | 27.03% | 30.05% | 30.26% | 29.57% | 29.56% |
ISRG | total::revenue | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
ISRG | u.s. | instruments and accessories::total revenue | 42.94% | 40.29% | 38.97% | 40.96% | 39.97% | 39.87% | 40.25% | 39.79% |
ISRG | u.s. | services::total revenue | 10.71% | 10.99% | 10.56% | 11.06% | 11.34% | 12.24% | 13.35% | 13.93% |
ISRG | u.s. | systems::total revenue | 12.14% | 15.53% | 17.93% | 15.95% | 18.53% | 18.58% | 19.21% | 18.51% |
ISRG | u.s.::total revenue | 65.80% | 66.81% | 67.48% | 67.96% | 69.87% | 70.70% | 72.81% | 72.27% |
Ticker | Entry | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ISRG | earnings per share::add: dilutive effect of potential common shares | 0.0 | 6.00 | 9.00 | 9.00 | 12.00 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | earnings per share::add: dilutive potential shares | 0.0 | 0.0 | 0.0 | 3.00 | 4.00 | 5.00 | 4.00 | 3.00 | 2.00 | 3.00 | 2.00 | 1.00 | 1.00 |
ISRG | earnings per share::basic | 5.12 | 3.72 | 4.79 | 9.06 | 11.95 | 9.92 | 6.01 | 19.21 | 15.87 | 11.35 | 17.12 | 16.50 | 12.63 |
ISRG | earnings per share::diluted | 5.03 | 3.65 | 4.66 | 8.82 | 11.54 | 9.49 | 5.77 | 18.73 | 15.54 | 11.11 | 16.73 | 15.98 | 12.32 |
ISRG | earnings per share::net income | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 660.00 | 735.90 | 588.80 | 418.80 | 671.00 | 656.60 | 495.10 |
ISRG | earnings per share::net income attributable to intuitive surgical, inc. | 0.0 | 0.0 | 0.00M | 0.00M | 0.00M | 0.00M | 670.90 | 738.30 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | weighted shares outstanding::diluted | 357.00M | 362.00M | 365.00M | 351.00M | 346.00M | 113.00M | 111.00M | 114.00M | 111.00M | 36.00M | 39.00M | 39.00M | 39.00M |
Ticker | Entry |
---|---|
ISRG | earnings per share::add: dilutive effect of potential common shares |
ISRG | earnings per share::add: dilutive potential shares |
ISRG | earnings per share::basic |
ISRG | earnings per share::diluted |
ISRG | earnings per share::net income |
ISRG | earnings per share::net income attributable to intuitive surgical, inc. |
ISRG | weighted shares outstanding::diluted |
Ticker | Entry | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|---|
ISRG | instruments and accessories::total revenue | 4.28B | 3.52B | 3.10B | 2.46B | 2.41B | 1.96B | 1.64B | 1.40B |
ISRG | ous | instruments and accessories::total revenue | 1.22B | 1.01B | 0.88B | 0.67B | 0.62B | 0.48B | 0.37B | 0.32B |
ISRG | ous | services::total revenue | 0.40B | 0.34B | 0.31B | 0.24B | 0.22B | 0.18B | 0.15B | 0.13B |
ISRG | ous | systems::total revenue | 0.81B | 0.71B | 0.67B | 0.48B | 0.52B | 0.43B | 0.32B | 0.30B |
ISRG | ous::total revenue | 2.44B | 2.06B | 1.86B | 1.40B | 1.35B | 1.09B | 0.85B | 0.75B |
ISRG | product::total revenue | 0.0 | 5.20B | 4.79B | 3.63B | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | services::total revenue | 1.17B | 1.02B | 0.92B | 0.72B | 0.72B | 0.64B | 0.57B | 0.51B |
ISRG | systems::total revenue | 1.68B | 1.68B | 1.69B | 1.18B | 1.35B | 1.13B | 0.93B | 0.80B |
ISRG | total::revenue | 7.12B | 6.22B | 5.71B | 4.36B | 4.48B | 3.72B | 3.14B | 2.71B |
ISRG | u.s. | instruments and accessories::total revenue | 3.06B | 2.51B | 2.23B | 1.78B | 1.79B | 1.49B | 1.26B | 1.08B |
ISRG | u.s. | services::total revenue | 0.76B | 0.68B | 0.60B | 0.48B | 0.51B | 0.46B | 0.42B | 0.38B |
ISRG | u.s. | systems::total revenue | 0.86B | 0.97B | 1.02B | 0.69B | 0.83B | 0.69B | 0.60B | 0.50B |
ISRG | u.s.::total revenue | 4.69B | 4.16B | 3.85B | 2.96B | 3.13B | 2.63B | 2.29B | 1.96B |
Ticker | Entry | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|---|
ISRG | instruments and accessories::total revenue | 60.02% | 56.52% | 54.29% | 56.33% | 53.77% | 52.68% | 52.13% | 51.54% |
ISRG | ous | instruments and accessories::total revenue | 17.07% | 16.23% | 15.32% | 15.37% | 13.78% | 12.78% | 11.89% | 11.75% |
ISRG | ous | services::total revenue | 5.68% | 5.46% | 5.48% | 5.53% | 4.82% | 4.81% | 4.90% | 4.91% |
ISRG | ous | systems::total revenue | 11.43% | 11.48% | 11.70% | 11.08% | 11.50% | 11.65% | 10.32% | 11.01% |
ISRG | ous::total revenue | 34.18% | 33.17% | 32.50% | 32.01% | 30.12% | 29.27% | 27.15% | 27.71% |
ISRG | product::total revenue | 0.0 | 83.54% | 83.94% | 83.38% | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | services::total revenue | 16.38% | 16.46% | 16.04% | 16.59% | 16.17% | 17.05% | 18.23% | 18.84% |
ISRG | systems::total revenue | 23.57% | 27.00% | 29.65% | 27.03% | 30.05% | 30.26% | 29.57% | 29.56% |
ISRG | total::revenue | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
ISRG | u.s. | instruments and accessories::total revenue | 42.94% | 40.29% | 38.97% | 40.96% | 39.97% | 39.87% | 40.25% | 39.79% |
ISRG | u.s. | services::total revenue | 10.71% | 10.99% | 10.56% | 11.06% | 11.34% | 12.24% | 13.35% | 13.93% |
ISRG | u.s. | systems::total revenue | 12.14% | 15.53% | 17.93% | 15.95% | 18.53% | 18.58% | 19.21% | 18.51% |
ISRG | u.s.::total revenue | 65.80% | 66.81% | 67.48% | 67.96% | 69.87% | 70.70% | 72.81% | 72.27% |
Ticker | Entry | 2023 | 2022 |
---|---|---|---|
ISRG | revenue from contract with customer::contract assets | 20.20M | 45.00M |
ISRG | revenue from contract with customer::deferred revenue | 491.70M | 438.30M |
Ticker | Entry | 2023 | 2022 |
---|---|---|---|
ISRG | revenue from contract with customer::contract assets | 4.11% | 10.27% |
ISRG | revenue from contract with customer::deferred revenue | 100.00% | 100.00% |
Ticker | Entry | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ISRG | total revenues | 0.0 | 6.22B | 5.71B | 4.36B | 4.48B | 3.72B | 3.14B | 2.71B | 2.38B | 2.13B | 2.27B | 2.18B | 1.76B | 1.41B | 1.05B |
ISRG | net income | 1.82B | 1.34B | 1.73B | 1.07B | 1.38B | 1.12B | 0.67B | 0.74B | 0.59B | 0.42B | 0.67B | 0.66B | 0.50B | 0.38B | 0.23B |
ISRG | revenue::product | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.55B | 2.19B | 1.92B | 1.70B | 1.87B | 1.84B | 1.48B | 1.19B | 0.88B |
ISRG | revenue::service | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.58B | 0.52B | 0.46B | 0.43B | 0.40B | 0.34B | 0.28B | 0.22B | 0.17B |
ISRG | cost of revenue::product | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.75B | 0.66B | 0.65B | 0.57B | 0.54B | 0.49B | 0.38B | 0.30B | 0.24B |
ISRG | cost of revenue::service | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.18B | 0.15B | 0.16B | 0.15B | 0.13B | 0.11B | 0.10B | 0.09B | 0.06B |
ISRG | cost of revenue::gross profit | 4.73B | 4.20B | 3.96B | 2.86B | 3.11B | 2.60B | 2.20B | 1.89B | 1.58B | 1.41B | 1.59B | 1.57B | 1.27B | 1.03B | 0.75B |
ISRG | cost of revenue::total cost of revenue | 2.39B | 2.03B | 1.75B | 1.50B | 1.37B | 1.12B | 0.94B | 0.81B | 0.81B | 0.72B | 0.67B | 0.61B | 0.48B | 0.38B | 0.30B |
ISRG | product::cost of revenue::total cost of revenue | 2.04B | 1.70B | 1.46B | 1.23B | 1.12B | 0.91B | 0.76B | 0.66B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | product::revenue::total revenue | 5.96B | 5.20B | 4.79B | 3.63B | 3.75B | 3.09B | 2.56B | 2.19B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | service::cost of revenue::total cost of revenue | 0.35B | 0.33B | 0.29B | 0.27B | 0.25B | 0.21B | 0.18B | 0.15B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | service::revenue::total revenue | 1.17B | 1.02B | 0.92B | 0.72B | 0.72B | 0.64B | 0.57B | 0.51B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | costs and expenses::income before tax | 1.96B | 1.61B | 1.89B | 1.21B | 1.50B | 1.28B | 1.10B | 0.98B | 0.76B | 0.55B | 0.87B | 0.89B | 0.71B | 0.57B | 0.40B |
ISRG | costs and expenses::income tax expense | 0.14B | 0.26B | 0.16B | 0.14B | 0.12B | 0.15B | 0.44B | 0.25B | 0.17B | 0.13B | 0.20B | 0.24B | 0.21B | 0.19B | 0.16B |
ISRG | costs and expenses::income from operations | 1.77B | 1.58B | 1.82B | 1.05B | 1.37B | 1.20B | 1.06B | 0.95B | 0.74B | 0.54B | 0.85B | 0.88B | 0.69B | 0.56B | 0.38B |
ISRG | costs and expenses::research and development | 1.00B | 0.88B | 0.67B | 0.59B | 0.56B | 0.42B | 0.33B | 0.24B | 0.20B | 0.18B | 0.17B | 0.17B | 0.14B | 0.12B | 0.10B |
ISRG | costs and expenses::total operating expenses | 2.96B | 2.62B | 2.14B | 1.81B | 1.74B | 1.40B | 1.14B | 0.94B | 0.84B | 0.87B | 0.74B | 0.69B | 0.58B | 0.47B | 0.37B |
ISRG | costs and expenses::interest and other income, net | 0.19B | 0.03B | 0.07B | 0.16B | 0.13B | 0.08B | 0.04B | 0.04B | 0.02B | 0.00B | 0.02B | 0.01B | 0.01B | 0.02B | 0.02B |
ISRG | costs and expenses::selling, general and administrative | 1.96B | 1.74B | 1.47B | 1.22B | 1.18B | 0.99B | 0.81B | 0.70B | 0.64B | 0.69B | 0.57B | 0.52B | 0.44B | 0.36B | 0.28B |
ISRG | costs and expenses::net income attributable to intuitive surgical, inc. | 1.80B | 1.32B | 1.70B | 1.06B | 1.38B | 1.13B | 0.67B | 0.74B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | costs and expenses::less: net income attributable to noncontrolling interest in joint venture | 0.02B | 0.02B | 0.02B | 0.01B | 0.00B | -0.00B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | joint venture::operating expenses::less: net income attributable to noncontrolling interest in joint venture | 0.02B | 0.02B | 0.02B | 0.01B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | net income per share attributable to intuitive surgical, inc.::basic | 5.12 | 3.72 | 4.79 | 9.06 | 11.95 | 9.92 | 6.01 | 6.43 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | net income per share attributable to intuitive surgical, inc.::diluted | 5.03 | 3.65 | 4.66 | 8.82 | 11.54 | 9.49 | 5.77 | 6.26 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | shares used in computing net income per share attributable to intuitive surgical, inc.::total comprehensive income attributable to intuitive surgical, inc. | 0.0 | 0.0 | 1.66B | 1.07B | 1.41B | 1.13B | 0.66B | 0.74B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
ISRG | earnings per share::basic | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.91 | 19.21 | 15.87 | 11.35 | 17.12 | 16.50 | 12.63 | 9.74 | 6.07 |
ISRG | earnings per share::diluted | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.67 | 18.73 | 15.54 | 11.11 | 16.73 | 15.98 | 12.32 | 9.47 | 5.93 |
ISRG | weighted shares outstanding::diluted | 0.36B | 0.36B | 0.36B | 0.35B | 0.35B | 0.11B | 0.11B | 0.11B | 0.11B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
ISRG | total::revenue | 7.12B | 6.22B | 5.71B | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Ticker | Entry | 2023 | 2022 | 2021 |
---|---|---|---|---|
ISRG | total revenues | 0.0 | 100.00% | 100.00% |
ISRG | net income | 25.50% | 21.60% | 30.26% |
ISRG | cost of revenue::gross profit | 66.38% | 67.44% | 69.32% |
ISRG | cost of revenue::product | 0.0 | 0.0 | 0.0 |
ISRG | cost of revenue::service | 0.0 | 0.0 | 0.0 |
ISRG | cost of revenue::total cost of revenue | 33.60% | 32.56% | 30.66% |
ISRG | costs and expenses::income before tax | 27.48% | 25.81% | 33.10% |
ISRG | costs and expenses::income from operations | 24.79% | 25.34% | 31.89% |
ISRG | costs and expenses::income tax expense | 1.98% | 4.21% | 2.84% |
ISRG | costs and expenses::interest and other income, net | 2.70% | 0.47% | 1.21% |
ISRG | costs and expenses::less: net income attributable to noncontrolling interest in joint venture | 0.27% | 0.35% | 0.40% |
ISRG | costs and expenses::net income attributable to intuitive surgical, inc. | 25.24% | 21.25% | 29.85% |
ISRG | costs and expenses::research and development | 14.01% | 14.13% | 11.75% |
ISRG | costs and expenses::selling, general and administrative | 27.55% | 27.95% | 25.67% |
ISRG | costs and expenses::total operating expenses | 41.58% | 42.08% | 37.42% |
ISRG | earnings per share::basic | 0.0 | 0.0 | 0.0 |
ISRG | earnings per share::diluted | 0.0 | 0.0 | 0.0 |
ISRG | joint venture::operating expenses::less: net income attributable to noncontrolling interest in joint venture | 0.27% | 0.36% | 0.41% |
ISRG | net income per share attributable to intuitive surgical, inc.::basic | 0.0 | 0.0 | 0.0 |
ISRG | net income per share attributable to intuitive surgical, inc.::diluted | 0.0 | 0.0 | 0.0 |
ISRG | product::cost of revenue::total cost of revenue | 28.65% | 27.32% | 25.64% |
ISRG | product::revenue::total revenue | 83.60% | 83.54% | 83.94% |
ISRG | revenue::product | 0.0 | 0.0 | 0.0 |
ISRG | revenue::service | 0.0 | 0.0 | 0.0 |
ISRG | service::cost of revenue::total cost of revenue | 4.95% | 5.24% | 5.03% |
ISRG | service::revenue::total revenue | 16.38% | 16.46% | 16.04% |
ISRG | shares used in computing net income per share attributable to intuitive surgical, inc.::total comprehensive income attributable to intuitive surgical, inc. | 0.0 | 0.0 | 28.99% |
ISRG | total::revenue | 100.00% | 100.00% | 100.00% |
ISRG | weighted shares outstanding::diluted | 5.01% | 5.82% | 6.39% |